(Q38020419)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Immunity to the respiratory pathogen Bordetella pertussis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

R Higgs

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S C Higgins

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

P J Ross

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

20 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

485-500

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national causes of child mortality in 2008: a systematic analysis

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The present and future control of pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin targets airway macrophages to promote Bordetella pertussis infection of the respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pathology and pathogenesis of fatal Bordetella pertussis infection in infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Evidence for an intracellular niche for Bordetella pertussis in broncho-alveolar lavage cells of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Intracellular trafficking of Bordetella pertussis in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis commits human dendritic cells to promote a Th1/Th17 response through the activity of adenylate cyclase toxin and MAPK-pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Role of neutrophils in response to Bordetella pertussis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Antimicrobial peptides and proteins in the innate defense of the airway surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The host defense peptide beta-defensin 1 confers protection against Bordetella pertussis in newborn piglets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Expression of beta-defensins in the canine respiratory tract and antimicrobial activity against Bordetella bronchiseptica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Infection with Bordetella parapertussis but not Bordetella pertussis causes pertussis-like disease in older pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Suppression of NF-kappaB-mediated beta-defensin gene expression in the mammalian airway by the Bordetella type III secretion system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

BrkA protein of Bordetella pertussis inhibits the classical pathway of complement after C1 deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Growth phase influences complement resistance of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis acquires resistance to complement-mediated killing in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

O antigen protects Bordetella parapertussis from complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Activation of the complement cascade by Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Immunoglobulin A-mediated protection against Bordetella pertussis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Immunity to Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

A placebo-controlled trial of a pertussis-toxoid vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

IL-23 drives a pathogenic T cell population that induces autoimmune inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Human T cell clones define S1 subunit as the most immunogenic moiety of pertussis toxin and determine its epitope map.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis expresses a functional type III secretion system that subverts protective innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Innate IL-17-producing cells: the sentinels of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Th2-polarisation of cellular immune memory to neonatal pertussis vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

gammadelta T cells regulate the early inflammatory response to bordetella pertussis infection in the murine respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Regulatory T cells: friend or foe in immunity to infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis adenylate cyclase toxin modulates innate and adaptive immune responses: distinct roles for acylation and enzymatic activity in immunomodulation and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella evades the host immune system by inducing IL-10 through a type III effector, BopN

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella type III secretion and adenylate cyclase toxin synergize to drive dendritic cells into a semimature state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bacterial virulence gene regulation: an evolutionary perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis: a matter of immune modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis infection of human respiratory epithelial cells up-regulates intercellular adhesion molecule-1 expression: role of filamentous hemagglutinin and pertussis toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Phagocytosis ofBordetella pertussisIncubated with Convalescent Serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Recognition of a bacterial adhesion by an integrin: macrophage CR3 (alpha M beta 2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Monocyte-derived interleukin-10 depresses the Bordetella pertussis- specific gamma interferon response in vaccinated infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Modulation of the NF-kappaB pathway by Bordetella pertussis filamentous hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin has eukaryotic-like carbohydrate recognition domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis infection of primary human monocytes alters HLA-DR expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin utilizes proximal components of the T-cell receptor complex to initiate signal transduction events in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis infection exacerbates influenza virus infection through pertussis toxin-mediated suppression of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Role of the Bordetella pertussis P.69/pertactin protein and the P.69/pertactin RGD motif in the adherence to and invasion of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Molecular cloning and characterization of protective outer membrane protein P.69 from Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Pertactin is required for Bordetella species to resist neutrophil-mediated clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Biologic and protective properties of the 69-kDa outer membrane protein of Bordetella pertussis: a novel formulation for an acellular pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Role of CD11b/CD18 in the process of intoxication by the adenylate cyclase toxin of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Cell cycle arrest induced by the bacterial adenylate cyclase toxins from Bacillus anthracis and Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Adenylate cyclase toxin subverts phagocyte function by RhoA inhibition and unproductive ruffling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Adenylate cycalse toxin of Bordetella pertussis inhibits TLR-induced IRF-1 and IRF-8 activation and IL-12 production and enhances IL-10 through MAPK activation in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis inhibition of interleukin-12 (IL-12) p70 in human monocyte-derived dendritic cells blocks IL-12 p35 through adenylate cyclase toxin-dependent cyclic AMP induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Proinflammatory cytokines in the adverse systemic and neurologic effects associated with parenteral injection of a whole cell pertussis vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Monomeric and polymeric gram-negative peptidoglycan but not purified LPS stimulate the Drosophila IMD pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Primary structure of the peptidoglycan-derived tracheal cytotoxin of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Synergistic epithelial responses to endotoxin and a naturally occurring muramyl peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The type III secretion injectisome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

The Bpel locus encodes type III secretion machinery in Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Characterization of the type III secretion locus of Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Regulation of type III secretion in Bordetella

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

BopC is a novel type III effector secreted by Bordetella bronchiseptica and has a critical role in type III-dependent necrotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Laboratory adaptation of Bordetella pertussis is associated with the loss of type three secretion system functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordetella pertussis strains with increased toxin production associated with pertussis resurgence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Attenuating regulatory T cell induction by TLR agonists through inhibition of p38 MAPK signaling in dendritic cells enhances their efficacy as vaccine adjuvants and cancer immunotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Interactions between Bordetella pertussis and the complement inhibitor factor H

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

Bordatella pertussis respiratory infection in children Is associated with preferential activation of Type 1 T helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Bordetella pertussis Infection in 2-Month-Old Infants Promotes Type 1 T Cell Responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Role of gamma interferon in natural clearance of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

CD11c+CD8 + Dendritic Cells Promote Protective Immunity to Respiratory Infection with Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Uptake and intracellular survival of Bordetella pertussis in human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Interferon-γ mediated immune effector mechanisms against Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

The immunoregulatory role of CD4+FoxP3+CD25−regulatory T cells in lungs of mice infected withBordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Susceptibilities of Bordetella pertussis strains to antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Characterization of human bactericidal antibodies to Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Specific immunoglobulin for treatment of whooping cough

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Organogenic role of B lymphocytes in mucosal immunity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Cell-mediated immune responses to antigens of Bordetella pertussis and protection against pertussis in school children

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Cellular immunity in pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Direct anti-inflammatory effect of a bacterial virulence factor: IL-10-dependent suppression of IL-12 production by filamentous hemagglutinin fromBordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Adenylate cyclase influences filamentous haemagglutinin-mediated attachment of Bordetella pertussis to epithelial alveolar cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Role of carbohydrate recognition domains of pertussis toxin in adherence of Bordetella pertussis to human macrophages

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Influence of pertussis toxin on CD1a isoform expression in human dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Pertussis toxin enhances Th1 responses by stimulation of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Genetic basis for lipopolysaccharide O-antigen biosynthesis in bordetellae

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Interleukin-1β-dependent changes in the hippocampus following parenteral immunization with a whole cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Protective effectiveness of an endotoxin-depleted pertussis vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Effect of tracheal cytotoxin from Bordetella pertussis on human neutrophil function in vitro

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine

1 reference

https://api.crossref.org/works/10.1038%2FMI.2012.54

7 January 2021

Identifiers

DOI

10.1038/MI.2012.54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 February 2020

1047483713

0 references

Fatcat ID

release_dxykrdhb5zbl7fz4umc7jsrbzu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dxykrdhb5zbl7fz4umc7jsrbzu

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22718262%20AND%20SRC:MED&resulttype=core&format=json